Use of cardiac magnetic resonance (CMR) imaging to screen competitive collegiate athletes with COVID-19 may increase detection of clinical and subclinical myocarditis, according to a study published May 27 in JAMA Cardiology. "At present, we do not know the natural history of the short- and long-term implications to an athlete with COVID-19 clinical or subclinical myocarditis," write Curt J. Daniels, MD, FACC, et al. "To address these concerns, we must find ways to minimize the variability in performance among academic centers to diagnose myocarditis, perhaps through standardized evidence-based diagnostic algorithms and testing protocols, and when indicated, standardization of CMR protocols and interpretation." Read more. ACC's Care of the Athletic Heart Virtual: From Elite to Exercise Enthusiasts will take place virtually June 24 – 26 and feature sessions on COVID-19, including the keynote session "Coronavirus-2019: Current Perspectives from the Lockdown to the Present," three cases on COVID-19 and the athletic heart, and more. Register now.